Pharmacoepidemiology Roundtables  1998-1999



The Pharmacoepidemiology Roundtables are informal discussions intended for students in
the Pharmacoepidemiology concentration (SM, MPH or SD, DPH). However, if you know of students who are interested in this type of discussion, please feel free to extend an invitation.
Students and research fellows present their recent or current experiences and research topics.
Pharmacoepi Roundtables are brown bag meetings.

LOCATION:       Epidemiology Library
                            Harvard School of Public Health
                            677 Huntington Avenue
                            Room  904, Kresge Building
                            Boston, MA 02115

TIME:                  12:30-1:30


Please check this page for confirmations and changes.

Mo. Oct. 26, 1998         Linda Marc, MPH
                                      Automating surveillance for the analysis
                                      of adverse event case reports.

Mo. Nov. 30, 1998        Sebastian Schneeweiss MD, SM
                                      Evaluating differential cost sharing of drugs
                                      using administrative databases.
 

Th. Feb. 25, 1999          John Seeger, PharmD, MPH
                                      Characteristics associated with ability
                                      to prevent adverse drug reactions
                                      in hospitalized patients

Th. Mar. 18, 1999        Sonja Hernandez-Diaz, MD, MPH
                                     Periconceptional Use of Trimethoprim
                                     in Relation to Neural Tube Defects

Th. April 22, 1999       Jim Kaye, MD
                                     New Safety Issues in the Clinical Development
                                     of Platelet Growth Factors


If you have questions or comments about the Seminars or want to be included in a mailing list, please send an e-mail to Kathy Putnam.

Return to the top of this document

Return to DDIL HOMEPAGE

This document has been provided through the Drugs and Devices Information Line, http://www.hsph.harvard.edu/Organizations/DDIL/ddil.html
If you have questions or comments about the DDIL, please write to: sschneew@hsph.harvard.edu